NCT01068782 2026-02-25Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseExelixisPhase 2 Terminated19 enrolled 10 charts
NCT02885324 2022-10-06Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in ChildrenIndiana UniversityPhase 2 Terminated4 enrolled 6 charts